Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist

Webinar/Online

Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT
This event has ended.

Gastric Cancers

This event offers 1.0 CME credit to attendees.
Accreditation Info: Accreditation Council for Continuing Medical Education.

Join us for this great CME talk.

Learning Objectives:

Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options

Thomas H. Cartwright MD

Associate Professor

Dr. Thomas Cartwright is an Associate Professor of Medicine at the University of Central Florida School of Medicine in Ocala, FL.

Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT

All times listed in Central Time (US & Canada).
Download event agenda (PDF)

7:00pm - 8:00pm

Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist

Thomas H. Cartwright, MD
1.0 CE Credit

Learning Objectives:
- Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
- Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
- Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options